Convalescent Plasma / Hamilton Health Sciences Corporation - LARVOL DELTA

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) (clinicaltrials.gov) - P3; N=940; Terminated; Sponsor: Hamilton Health Sciences Corporation; Active, not recruiting ➔ Terminated; Study was terminated after the planned interim analysis as the pre-defined futility threshold was met

Clinical • Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. (PubMed, Trials) - P3 | "This trial will determine whether CCP will reduce intubation or death non-intubated adults with COVID-19. The trial will also provide information on the role of and thresholds for SARS-CoV-2 antibody titres and neutralization assays for donor qualification."

Clinical • Journal • Critical care • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) (clinicaltrials.gov) - P3; N=1200; Active, not recruiting; Sponsor: Hamilton Health Sciences Corporation; Recruiting ➔ Active, not recruiting; Trial completion date: Dec 2020 ➔ Mar 2021; Trial primary completion date: Oct 2020 ➔ Mar 2021

Clinical • Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

CONCOR-1: A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (clinicaltrials.gov) - P3; N=1200; Recruiting; Sponsor: Weill Medical College of Cornell University; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease

CONCOR-1: A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (clinicaltrials.gov) - P3; N=1200; Not yet recruiting; Sponsor: Weill Medical College of Cornell University

Clinical • New P3 trial • Infectious Disease • Novel Coronavirus Disease

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) (clinicaltrials.gov) - P3; N=1200; Recruiting; Sponsor: Hamilton Health Sciences Corporation; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) (clinicaltrials.gov) - P3; N=1200; Not yet recruiting; Sponsor: Hamilton Health Sciences Corporation

Clinical • New P3 trial